MicroMed Technology Company

According to American Heart Association statistics, 20,000-40,000 patients in the United States would benefit from a heart transplant. The MicroMed DeBakey VAD®, jointly developed with Dr. Michael DeBakey, Dr. George Noon and the National Aeronautics and Space Administration (NASA), has the potential to keep many of these people alive until a donor heart becomes available. Weighing less than four ounces, the device is silent and is approximately 1/10 the size of other pulsatile products on the market. The MicroMed DeBakey VAD® is designed to be a lower-cost, less invasive alternative to the commercially available, larger ventricular assist devices (VADs).
Technology: Regenerative Medicine
Industry: Health Care, Medical Device, Wellness
Headquarters: Houston, Texas, United States
Founded Date: 1998-11-01
Funding Status: Late Stage Venture
Investors Number: 6
Total Funding: $40.6M
Last Funding Type: Series D

Visit Website
Register and Claim Ownership